Advertisement

Lung Cancer | Tumor

CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.

Expert Discusses Chemo Shortage: ‘Likely to Last’ 3 to 4 Months

June 12th 2023

A survey of cancer centers found that the majority of large centers are facing cisplatin and carboplatin shortages, and some are changing or delaying treatment because of it.

Shannen Doherty’s Cancer Metastasized, Nonprofit Established in Memory of Technoblade and More

June 9th 2023

From Shannen Doherty’s announcement that her breast cancer spread to her brain to a nonprofit being established in memory of the late YouTuber, Technoblade, here’s what’s happening in the oncology space this week.

ctDNA May Help Predict Lung Cancer Outcomes, Guide Treatment

June 7th 2023

Patients with non-small cell lung cancer who cleared 50% or more of cancerous DNA from their blood by their fourth treatment cycle tended to have better outcomes on maintenance therapy, research showed.

Tumor Treating Fields With Standard of Care May Significantly Improve Survival in Metastatic NSCLC

June 6th 2023

Tumor treating fields therapy “is a potentially paradigm-shifting new treatment modality” for metastatic non-small cell lung cancer, says Dr. Ticiana Leal.

Pre- and Post-Surgical Keytruda Boosts Outcomes in Early NSCLC

June 4th 2023

Adding Keytruda to pre-surgical chemotherapy then giving it again after surgery improved event-free survival and pathologic complete response in patients with early-stage lung cancer.

FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset

May 31st 2023

The agency accepted a New Drug Application for repotrectinib, a TKI for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.

Educated Patient® Lung Cancer Summit Looking Ahead Panel: April 29, 2023

May 24th 2023

Watch Dr. Jyoti Malhotra and Ken Culver answer questions about the future of the disease during the CURE® Educated Patient® Lung Cancer Summit.

First U.S. Patient Treated in Study of Novel Drug-Chemo Combo for NSCLC Subset

May 23rd 2023

Work is underway in the global phase 3 HARMONi study evaluating the combination of ivonescimab and chemotherapy in the treatment of patients with EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer.

Educated Patient® Lung Cancer Summit Advancements in Advanced-Stage NSCLC Presentation: April 29, 2023

May 23rd 2023

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced non-small cell lung cancer during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Advancements in Early-Stage NSCLC Presentation: April 29, 2023

May 22nd 2023

Watch Dr. Erminia Massarelli, from City of Hope National Medical Center, discuss advancements in early-stage non-small cell disease during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Advancements in SCLC Presentation: April 29, 2023

May 21st 2023

Watch Dr. Ravi Salgia, from City of Hope, discuss advancements in small cell lung cancer during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Targeted Treatment Panel: April 29, 2023

May 20th 2023

Watch Dr. Ed Kim, Dr. Jyoti Malhotra and Terri Conneran answer questions about targeted therapy during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Targeted Therapies Presentation: April 29, 2023

May 19th 2023

Watch Dr. Jyoti Malhotra, from City of Hope Orange County, discuss targeted therapy, during the CURE® Educated Patient® Lung Cancer Summit.

Tagrisso-Chemo Combo Improves Progression-Free Survival in NSCLC Subset

May 18th 2023

Tagrisso plus chemotherapy improved progression-free survival in patients with EGFR-mutated, locally advanced or metastatic non-small cell lung cancer, according to high-level results from a phase 3 trial.

Educated Patient® Lung Cancer Summit Biomarker Testing Presentation: April 29, 2023

May 18th 2023

Watch an expert discuss biomarker testing during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Basics of Lung Cancer Panel: April 29, 2023

May 17th 2023

Watch Dr. Thomas Waddington and Dr. Percy Lee answer questions about diagnostic and radiation advances during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Radiation Advances Presentation: April 29, 2023

May 16th 2023

Watch Dr. Percy Lee, from City of Hope, discuss radiation advances during the CURE® Educated Patient® Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Advancements in Diagnosis: April 29, 2023

May 15th 2023

Watch Dr. Thomas Waddington, from City of Hope National Medical Center, discuss the past and future of bronchoscopy during the CURE® Educated Patient® Lung Cancer Summit.

Enrollment Open for a Trial of Novel Drug-Chemo Combo for Lung Cancer

May 10th 2023

The phase 3 HARMONi trial recently kicked off, studying ivonescimab plus chemotherapy for EGFR-mutant non-small cell lung cancer.

Tyvyt Plus Chemo Improved Outcomes in NSCLC Subset

May 9th 2023

The benefit derived from Tyvyt plus chemotherapy was present regardless of whether previously treated patients with EGFR-mutated, non-squamous non-small cell lung cancer also received Byvasda.

Hello Cancer, Pleased to Meet You

May 8th 2023

I’ve learned that knowledge is the key to fighting cancer. Here are three ways I learn more about my disease.

A Cancer Survivor's Story

May 6th 2023

Deborah Lorick, M.S.N., M.H.A., RN, RNOCN, was the assistant nurse manager on the oncology unit where my husband was a patient. Deborah was always making sure that my husband, my children and I were well cared for.

Inflammatory Biomarkers From Lung Cancer, Depression May Predict Survival Outcomes

April 17th 2023

The inflammation associated with lung cancer and depression may impact survival, despite treatments like immunotherapy and targeted therapies.

Taking Cancer Support to a New Level

April 15th 2023

Supportive care commonly addresses physical symptoms associated with lung cancer and side effects associated with cancer therapy.

Lung Cancer Trial Has Broader Eligibility Criteria, Overcomes Barriers

April 14th 2023

The phase 3 Pragmatica-Lung study evaluating Cyramza and Keytruda has broader eligibility criteria than many other trials, expanding access to more patients and clinicians.

Early Supportive Care Extends Life, Eases Cancer Symptoms

April 13th 2023

More awareness is needed to understand the benefits of both supportive care and palliative care in lung cancer.

Doing More With Less in Lung Cancer Surgery

April 13th 2023

For some patients with non-small cell lung cancer, removing part of the lobe rather than the entire lobe still provides benefit, study results show.

First Patient Dosed in Phase 1/2 Trial Assessing Novel Immunotherapy Alone, With Keytruda

April 12th 2023

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.

The Way of the Future for Treating Early-Stage NSCLC

April 12th 2023

Treatment for patients with non-small cell lung cancer has evolved to include immunotherapy after surgery and chemotherapy.

Standard Treatment May Not Be Best for Exon 20-Mutant Lung Cancer

April 8th 2023

Rybrevant outperformed other therapies for patients with exon 20 insertion-mutant, advanced non-small cell lung cancer in a clinical trial, highlighting the importance of personalized medicine.

NEXT PAGE
PREVIOUS PAGE
Advertisement
Advertisement